05 Jan FluGen to Present at the 40th Annual J.P. Morgan Healthcare Conference
Posted at 16:45h in Featured, Resident Company News, URP News
FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced that the Company will present at the 40th Annual J.P. Morgan Healthcare Conference, which is being held virtually on January 10-13, 2022. Boyd Clarke, Executive Chairman is scheduled to present via the live conference webcast on Wednesday, January 12 at 4:30 PM E.T.
Invited attendees of the Conference can access the virtual session for both live and on demand replay.